- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.27 Angiodynamics, Inc. Fiscal Year 2011 Senior Executive Cash Incentive Program
- 10.28 Angiodynamics, Inc. Fiscal Year 2011 Senior Executive Equity Incentive Program
- 10.29 Angiodynamics, Inc. Fiscal Year 2012 Senior Executive Cash Incentive Program
- 10.30 Angiodynamics, Inc. Fiscal Year 2012 Senior Executive Equity Incentive Program
- 21 Subsidiaries
- 23 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification by the Chief Executive Officer Pursuant to Section 302
- 31.2 Certification by the Chief Financial Officer Pursuant to Section 302
- 32.1 Certification by the Chief Executive Officer Pursuant to 18 U.s.c. Section
- 32.2 Certification by the Chief Financial Officer Pursuant to 18 U.s.c. Section
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,
UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, D. Joseph Gersuk, Executive Vice President, Chief Financial Officer of ANGIODYNAMICS, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:
1. the annual report on Form 10-K of the Company for the fiscal year ended May 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 12, 2011 | /s/ D. JOSEPH GERSUK | |
D. Joseph Gersuk, | ||
Executive Vice President—Chief Financial Officer and Treasurer |